Target intelligence / Profile preview

RNA, U6 small nuclear 1081, pseudogene (RNU6-1081P)

Target
RNU6-1081P
Molecular classification
Pseudogene, Small nuclear RNA-derived pseudogene, Non-coding RNA pseudogene
01

Overview

RNU6-1081P is a pseudogene derived from the highly conserved U6 small nuclear RNA (snRNA), a component of the spliceosome critical for pre-mRNA splicing in eukaryotic nuclei. The genome contains many copies of U6 snRNA genes and pseudogenes; the latter, such as RNU6-1081P, are the result of retrotranspositional events and do not code for functional RNA or protein products. Pseudogenes like RNU6-1081P generally have no biological activity but can serve as markers of genome dynamics (such as retrotransposition) and may occasionally play roles in regulating gene expression through RNA-based mechanisms, though this is not described for RNU6-1081P itself. No disease relevance or functional activity has been assigned to this specific pseudogene. In summary: RNU6-1081P is a non-functional, non-protein-coding pseudogene derived from the U6 small nuclear RNA gene. It is not a drug target, receptor, or clinically relevant biomolecule.

Other names
RNU6-1081PU6 snRNA pseudogeneU6 small nuclear RNA pseudogene
02

Mechanism of action

None. As a pseudogene, RNU6-1081P does not encode a protein or functional RNA product, nor does it have a mechanism of action.

03

Biological functions

No known biological function as a pseudogene.The parental gene (U6 small nuclear RNA; U6 snRNA) is essential for RNA splicing, but pseudogenes like RNU6-1081P do not participate in this process.
04

Disease associations

Pseudogenes in general may serve as markers for retrotransposition dynamics or genomic instability, but there are no direct disease associations or direct functional roles for RNU6-1081P specifically.Some pseudogenes have been implicated in disease *via* RNA-mediated regulatory functions, but such roles have not been described for RNU6-1081P.
05

Safety considerations

None. As a non-coding, non-functional pseudogene, it presents no safety or therapeutic concerns.
06

Interacting drugs

None known. No evidence that this pseudogene interacts with drugs.
07

Biomarkers

None. There is no evidence that RNU6-1081P functions as a biomarker for patient selection or efficacy monitoring.

Beyond the preview

Go deeper on RNA, U6 small nuclear 1081, pseudogene (RNU6-1081P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1081, pseudogene (RNU6-1081P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call